Sigurd Leyck

This inventor holds 16 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: A. Nattermann & Cie Gmbh, Nattermann & Cie Gmbh. Active years: 1983-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sigurd Leyck. Retrieved from https://idiyas.com/inventor/sigurd-leyck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16

% Patents Active = 100.0

Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 108(Granted Patents)

Location History:

Brauweiler, DE (1984)
Tubingen, DE (1986)
Pulheim, DE (1983 - 1992)

Company Filing History:

15 out of 94

A. Nattermann & Cie Gmbh

patents

1 out of 5

Nattermann & Cie Gmbh

patents

Years Active: 1983-1992

Loading Chart...

Areas of Expertise:

Anti-Inflammatory

Benzylselenobenzamides

Pharmaceutical Preparation

Therapeutic Treatment

Rheumatic

Formulation

Thienyl-Compounds

Selenazolones

Acid Derivatives

Glutathione

Aminopyridines

Cycloalkyl Derivatives

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5141955 - Anti-inflammatory benzylselenobenzamides made from anilines and (1992-08-25),

2. 5114954 - Antiinflammatory benzylselenobenzamides from aminopyridines and (1992-05-19),

3. 4910313 - Diselenobis benzoic acid amides of primary heterocyclic amines, process (1990-03-20),

4. 4730053 - S-[2-phenyl (alkyl) carbamoyl]-phenylselenylmercapto derivatives (1988-03-08),

5. 4711961 - Benzisoselenazolethiones and process for the treatment of various (1987-12-08),

6. 4705802 - Omega-aryl-alkylthienyl-compounds and process for the treatment of (1987-11-10),

7. 4687766 - Pharmaceutical preparation for the therapeutic treatment of rheumatic (1987-08-18),

8. 4684632 - Formulation with special 1,2-diacylglycero-3-phosphocholines for the (1987-08-04),

9. 4667033 - Substituted 6-(thien-2-yl)-3(2H)-pyridazinones (1987-05-19),

10. 4618669 - S-(carbamoyl-phenylselenyl) derivatives of glutathione and of (1986-10-21),

11. 4610979 - O-acyl-alkanediol-phospholipids and processes for the treatment of asthma (1986-09-09),

12. 4600722 - 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazolines and a (1986-07-15),

13. 4550168 - Benzisoselenazolones and a process for the treatment of inflammatory (1985-10-29),

14. 4464379 - Indol acetic acid derivatives and anti-inflamatory and related uses (1984-08-07),

15. 4454068 - Cycloalkyl derivatives of benzisoselenazolones (1984-06-12),

Title: Sigurd Leyck: Innovator in Anti-Inflammatory Compounds

Introduction

Sigurd Leyck is a notable inventor based in Pulheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compounds. With a total of 16 patents to his name, Leyck's work has had a considerable impact on medical research and treatment options.

Latest Patents

Leyck's latest patents include innovative compounds such as anti-inflammatory benzylselenobenzamides made from anilines. These compounds are characterized by their unique formula, where R can be hydrogen, methyl, or ethyl. Additionally, he has developed anti-inflammatory benzylselenobenzamides derived from aminopyridines, which exhibit inflammation-inhibiting characteristics and are utilized in pharmaceutical preparations.

Career Highlights

Throughout his career, Leyck has worked with prominent companies, including A. Nattermann & Cie GmbH. His expertise in the field has allowed him to contribute to various projects that focus on improving health outcomes through innovative pharmaceutical solutions.

Collaborations

Leyck has collaborated with esteemed colleagues such as Andre Welter and Eugen Etschenberg. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Sigurd Leyck's contributions to the field of pharmaceuticals, particularly in anti-inflammatory compounds, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving patient care.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]